464 related articles for article (PubMed ID: 20594269)
1. Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases.
Shiomi T; Lemaître V; D'Armiento J; Okada Y
Pathol Int; 2010 Jul; 60(7):477-96. PubMed ID: 20594269
[TBL] [Abstract][Full Text] [Related]
2. Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.
Hida Y; Hamada J
Anticancer Agents Med Chem; 2012 Sep; 12(7):744-52. PubMed ID: 22292754
[TBL] [Abstract][Full Text] [Related]
3. The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.
Binder MJ; Ward AC
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808504
[TBL] [Abstract][Full Text] [Related]
4. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
Zhong S; Khalil RA
Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
6. [Progress of research in osteoarthritis. Metalloproteinases in osteoarthritis].
Okada A; Okada Y
Clin Calcium; 2009 Nov; 19(11):1593-601. PubMed ID: 19880991
[TBL] [Abstract][Full Text] [Related]
7. ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.
Yang H; Khalil RA
Adv Pharmacol; 2022; 94():255-363. PubMed ID: 35659374
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of MMPs and ADAM/ADAMTS.
Malemud CJ
Biochem Pharmacol; 2019 Jul; 165():33-40. PubMed ID: 30826330
[TBL] [Abstract][Full Text] [Related]
9. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer.
Rocks N; Paulissen G; El Hour M; Quesada F; Crahay C; Gueders M; Foidart JM; Noel A; Cataldo D
Biochimie; 2008 Feb; 90(2):369-79. PubMed ID: 17920749
[TBL] [Abstract][Full Text] [Related]
10. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
11. [Destruction of the articular cartilage in osteoarthritis].
Okubo M; Okada Y
Clin Calcium; 2013 Dec; 23(12):1705-13. PubMed ID: 24292524
[TBL] [Abstract][Full Text] [Related]
12. A Hypothesis for the Role of RECK in Angiogenesis.
Gutiérrez J; Droppelmann CA; Salsoso R; Westermeier F; Toledo F; Salomon C; Sanhueza C; Pardo F; Leiva A; Sobrevia L
Curr Vasc Pharmacol; 2016; 14(1):106-15. PubMed ID: 26463982
[TBL] [Abstract][Full Text] [Related]
13. Role of ADAM and ADAMTS metalloproteinases in airway diseases.
Paulissen G; Rocks N; Gueders MM; Crahay C; Quesada-Calvo F; Bekaert S; Hacha J; El Hour M; Foidart JM; Noel A; Cataldo DD
Respir Res; 2009 Dec; 10(1):127. PubMed ID: 20034386
[TBL] [Abstract][Full Text] [Related]
14. The Biochemistry and Physiology of A Disintegrin and Metalloproteinases (ADAMs and ADAM-TSs) in Human Pathologies.
Sharma D; Singh NK
Rev Physiol Biochem Pharmacol; 2023; 184():69-120. PubMed ID: 35061104
[TBL] [Abstract][Full Text] [Related]
15. A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease.
Johnston P; Chojnowski AJ; Davidson RK; Riley GP; Donell ST; Clark IM
J Hand Surg Am; 2007 Mar; 32(3):343-51. PubMed ID: 17336841
[TBL] [Abstract][Full Text] [Related]
16. Extracellular regulation of metalloproteinases.
Yamamoto K; Murphy G; Troeberg L
Matrix Biol; 2015; 44-46():255-63. PubMed ID: 25701651
[TBL] [Abstract][Full Text] [Related]
17. Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.
Rivera S; García-González L; Khrestchatisky M; Baranger K
Cell Mol Life Sci; 2019 Aug; 76(16):3167-3191. PubMed ID: 31197405
[TBL] [Abstract][Full Text] [Related]
18. Matrix Metalloproteinases: How Much Can They Do?
Ågren MS; Auf dem Keller U
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK.
Siddesha JM; Valente AJ; Sakamuri SS; Yoshida T; Gardner JD; Somanna N; Takahashi C; Noda M; Chandrasekar B
J Mol Cell Cardiol; 2013 Dec; 65():9-18. PubMed ID: 24095877
[TBL] [Abstract][Full Text] [Related]
20. Role of ADAM and ADAMTS proteases in pathological tissue remodeling.
Wang Z; Li W; Chen S; Tang XX
Cell Death Discov; 2023 Dec; 9(1):447. PubMed ID: 38071234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]